Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer

Although platinum-based chemotherapy remains the “standard” in advanced non small-cell lung cancer, not all patients derive clinical benefit from such a treatment. Hence, the development of predictive biomarkers able to identify lung cancer patients who are most likely to benefit from cisplatin-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Mountzios, Giannis, Dimopoulos, Meletios-Athanasios, Papadimitriou, Christos
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688360/
https://www.ncbi.nlm.nih.gov/pubmed/19578506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688360/
https://www.ncbi.nlm.nih.gov/pubmed/19578506

Ejemplares similares